Creative Medical Technology Holdings (CELZ) Shares Outstanding (2010 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Shares Outstanding (Entity) came in at $1.3 million in Q3 2024, down 4.4% year-over-year from $1.4 million in Q4 2023, and down 0.62% quarter-over-quarter from $1.3 million in Q2 2024.
Analysis
Creative Medical Technology Holdings (CELZ) Shares Outstanding (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Shares Outstanding (Entity) for 15 consecutive years, with $1.3 million the latest figure, recorded in Q3 2024.
- On a quarterly basis, Shares Outstanding (Entity) fell 4.4% year-over-year to $1.3 million in Q3 2024; TTM through Sep 2024 was $1.3 million, a 4.4% decrease from a year earlier, with the FY2023 full-year figure at $1.4 million, up 25.65% from the prior year.
- Shares Outstanding (Entity) was $1.3 million for Q3 2024 at Creative Medical Technology Holdings, down from $1.3 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $136.3 million in Q3 2020 and troughed at $227712.0 in Q1 2021.
- A 5-year average of $10.6 million and a median of $1.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) jumped 2701.18% in 2020 and slumped 99.82% in 2021, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $29.0 million in 2020, then sank by 99.1% to $260506.0 in 2021, then soared by 319.65% to $1.1 million in 2022, then climbed by 25.65% to $1.4 million in 2023, then decreased by 3.19% to $1.3 million in 2024.
- The last three Shares Outstanding (Entity) figures came in at $1.3 million (Q3 2024), $1.3 million (Q2 2024), and $1.4 million (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 29.53 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 96.51 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 450.19 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 184.32 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 66.24 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 104.33 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 356.89 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 105.43 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 51.08 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | 1.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 901,125.00 |
| Mar 31, 2022 | 645,402.00 |
| Dec 31, 2021 | 260,506.00 |
| Sep 30, 2021 | 245,208.00 |